Any feedback?
Please rate this page
(literature.php)
(0/150)

BRENDA support

Literature summary for 1.1.1.21 extracted from

  • Koukoulitsa, C.; Bailly, F.; Pegklidou, K.; Demopoulos, V.J.; Cotelle, P.
    Evaluation of aldose reductase inhibition and docking studies of 6-nitro and 6,6-dinitrorosmarinic acids (2010), Eur. J. Med. Chem., 45, 1663-1666.
    View publication on PubMed

Application

Application Comment Organism
medicine aldose reductase ALR2 is a target enzyme for the treatment of diabetic complications Homo sapiens

Inhibitors

Inhibitors Comment Organism Structure
6',6''-dinitrorosmarinic acid docking structure with ALR2, overview Homo sapiens
6'-nitrorosmarinic acid docking structure with ALR2, overview Homo sapiens
rosmarinic acid docking structure with ALR2, overview Homo sapiens

Organism

Organism UniProt Comment Textmining
Homo sapiens P15121 ALR2
-

Synonyms

Synonyms Comment Organism
aldose reductase
-
Homo sapiens
ALR2
-
Homo sapiens

General Information

General Information Comment Organism
metabolism aldose reductase ALR2 acts in the polyol metabolic pathway Homo sapiens